89 results
Page 2 of 5
8-K
EX-99.1
dj79z9crq4v93c
24 Mar 22
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
4:12pm
8-K
EX-99.2
s188di8dm5 s95vxiy
24 Mar 22
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
4:12pm
8-K
EX-99.2
z96i5p4a06yq 7f9alt4
15 Nov 21
Regulation FD Disclosure
11:32am
8-K
EX-99.1
raomr
10 Nov 21
PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights
4:35pm
8-K
EX-99.2
mzads7k
10 Nov 21
PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights
4:35pm
8-K
EX-99.1
r45koo xz3n
12 Aug 21
PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
10:11am
8-K
EX-99.2
scvm mg6z5vuk7ox
12 Aug 21
PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
10:11am
8-K
e3lp8
17 Jun 21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab
8:13am
8-K
EX-99.1
u6xbhku i0j
13 May 21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
4:06pm
8-K
EX-99.2
j2l4q33n
13 May 21
PhaseBio Reports First-Quarter 2021 Financial Results and Recent Business Highlights
4:06pm
424B5
oe1rovha a2kb5y
19 Mar 21
Prospectus supplement for primary offering
4:04pm
424B5
m1xt madqocda
17 Mar 21
Prospectus supplement for primary offering
5:07pm